# A Study to Evaluate the Efficacy and Safety of DA-5204

> **NCT02282670** · PHASE3 · UNKNOWN · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 434 (actual)

## Conditions studied

- Acute Gastritis
- Chronic Gastritis

## Interventions

- **DRUG:** DA-5204
- **DRUG:** Stillen tab.

## Key facts

- **NCT ID:** NCT02282670
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 434 (ACTUAL)
- **Last updated:** 2014-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02282670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02282670, "A Study to Evaluate the Efficacy and Safety of DA-5204". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02282670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*